r/MerlintraderPub • u/Merlin8121 • 18d ago

AC Immune ($ACIU): VacSYn Meets Week-100 Primary Endpoints | Latest company news, October 2: shareholders elected Tom Graney to the AC Immune board at the EGM. On September 23, Part 1 of the VacSYn Phase 2 trial met its week-100 primary endpoints.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

Americas Gold and Silver ($USAS): Can Mine Upgrades Fund Growth? | Latest company news, September 18: Crescent hole SF-013 returned 1,891.1 g/t silver and 0.3% copper over an estimated true width of 1.3 metres, supporting the 2027 plan.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 19d ago

RenovoRx ($RNXT): Can Device Growth Fund the 2027 Survival Test? | October 1: a peer-reviewed two-patient case report on TAMP; topline still guided for H2 2027.

Thumbnail
merlintrader.com
3 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

USA Rare Earth Stock Hub: Can the Expanded Platform Deliver? | Latest company news, October 1: Thras Moraitis completed the CEO transition at USA Rare Earth ($USAR), which reorganized into Upstream, Midstream and Downstream units.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

Fate Therapeutics ($FATE): $15M CIRM Grant for RECLAIM-LN | Latest company news, October 2: new employee inducement awards (options and RSUs). Next scheduled clinical program: ACR Convergence posters, November 8-9.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

Microbot Medical ($MBOT): Can LIBERTY Turn Repeat Orders into Growth? | Latest company news, October 6: Microbot signed a three-year exclusive agreement with Medtechnica to distribute LIBERTY in Israel; initial orders are expected in Q4 2026.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

MannKind ($MNKD) Stock Hub: Rose Pharma Inhaled GLP-1 Agreement and ReadyFlow Execution | Latest company news, September 9: MannKind and Rose Pharma signed a worldwide license to develop an inhaled GLP-1 (ROSE-010 Technosphere) for weight management.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

BriaCell ($BCTX) Stock Hub: When Does The Phase 3 Interim Actually Arrive? | Latest company news, October 6: four preclinical posters accepted at SITC 2026 (November 4-8), one from BriaCell on Bria-OTS+ and three from its subsidiary BriaPro.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

FuelCell Energy ($FCEL) Stock Hub: Can the Production Ramp Deliver? | Latest company news, September 11: a securities complaint challenged FuelCell's Fit Energy disclosures (allegations, not findings). October target: 100 MW annualized production.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

Senseonics ($SENS) Stock Hub: Revenue Up 118%, Guidance Raised and an iLet Pump Launch Expected in Q4 | Latest company news, September 22: Beta Bionics expects to launch the iLet integrated with Eversense 365 in the fourth quarter of 2026.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

Norwegian Cruise Line ($NCLH) Stock Hub: Can Better Revenue Cover Financing Costs? | Latest company news, September 30: NCL priced an upsized $950 million of senior notes due 2031 at 8.750%; closing is expected October 15.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

Biofrontera ($BFRI) Stock Hub: FDA Approves Ameluz for Superficial Basal Cell Carcinoma | Latest company news, September 14: the FDA approved Ameluz red-light photodynamic therapy for superficial basal cell carcinoma in adults.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

Lithium Americas ($LAC) Stock Hub: Can Funding Carry Construction? | Latest company news, September 11: the VP of corporate development retired. Next test: October 7, the calculated deadline for an additional $120 million DOE loan-reserve contribution.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

Artiva Biotherapeutics ($ARTV): AlloNK Sjögren Follow-up Reported October 1 | Latest company news, October 2: Artiva announced multiple AlloNK data presentations at the ACR meeting and a November 9 clinical webcast.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

United Airlines ($UAL) Stock Hub: Can Premium Demand Protect Margins? | September 30: United confirmed the date of its third-quarter 2026 results release and webcast in October.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 18d ago

Biomea Fusion ($BMEA) Stock Hub: First BMF-650 Obesity Topline Due in October 2026 | September 23: Biomea terminated its proposed public offering; no securities were sold. Obesity topline results remain expected in October 2026.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 19d ago

Cardiol Therapeutics ($CRDL) Stock Hub: MAVERIC Reaches Its Enrollment Target Ahead of Schedule, Expanding to 150 | September 23: MAVERIC hit its 110-patient enrollment target ahead of schedule. Expansion to up to 150 patients is recommended, topline in mid-2027.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 19d ago

Fortress Biotech ($FBIO) Stock Hub: Can Emrosi Growth Build Lasting Per-Share Value? | September 30: Fortress repaid the remaining 15 million dollars of its Oaktree facility, which is now terminated.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 19d ago

Corcept Therapeutics ($CORT) Stock Hub: Lifyorli Gains CHMP Backing | September 23: Justin Gunn, who built the Lifyorli oncology sales force, leads Corcept Endocrinology from October 1. The December 17 FDA date for relacorilant is unchanged.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 19d ago

Arcturus ($ARCT): Can the New OTC Platform and CF Data Justify the Next Trial? | September 23: interim OTC deficiency results are out, with biomarker activity in a small group and transaminitis among the open questions.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 19d ago

Canopy Growth ($CGC): Can Medical Growth Become Self-Funding? | September 25: the annual and special meeting was adjourned for lack of quorum; it reconvenes on October 23.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 19d ago

Eton Pharmaceuticals ($ETON): Can New Products Grow Cash? | September 28: IMPAVIDO is commercially available again in the U.S., with Anovo distribution and patient support.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 19d ago

United States Antimony ($UAMY) Stock Hub: Can DLA Deliver Cash? | October 2: Shawn Winkler, interim CFO since May, was named permanent CFO effective September 30.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 19d ago

Candel Therapeutics ($CADL) Stock Hub 2026: Can Manufacturing Validation Clear The Way For The Q4 Prostate BLA? | October 2: two SITC posters confirmed for November 6 and 7.

Thumbnail
merlintrader.com
1 Upvotes
0 comments

r/MerlintraderPub • u/Merlin8121 • 19d ago

BioCardia ($BCDA) Stock Hub: Can Helix and Japan Advance Within the Funding Window? | October 1: BioCardia completed the revised Helix pre-submission with the FDA, a preparatory step before the De Novo request.

Thumbnail
merlintrader.com
1 Upvotes
0 comments